BiotechUni — International Biotech Community / 国际生物科技社区
国际生物科技社区 · Industry, R&D pipeline, funding & applications — industry trends, public R&D pipelines, funding notes, compliant applications & CRO/CDMO/tools. Bilingual CN+EN. Independent biotech industry community (complementary to DnaUni consumer DNA literacy). Not medical advice or diagnosis. No lab how-tos / pathogen enhancement. No politics.
CategoriesPick a board and join the discussion
Announcements / 站务公告
Forum news, bilingual rules, and official notices
Latest: 【招商】广告位刊例与首单优惠 / Advertise on BiotechUni
2026-10-24 09:00 北京时间
2026-10-24 09:00 北京时间
3 threads
3 posts
3 posts
Industry / 产业与政策环境
Public policy & industry environment notes — not legal advice
Latest: 与 DnaUni 如何互补:本站偏产业,彼站偏消费级检测解读 / Complementary …
2026-10-23 10:10 北京时间
2026-10-23 10:10 北京时间
3 threads
3 posts
3 posts
R&D Pipeline / 研发管线(公开信息)
Public pipeline reading fields — not lab instruction
Latest: 竞品对照表:写清对照维度 / Competitor pipeline worksheet
2026-10-23 15:00 北京时间
2026-10-23 15:00 北京时间
3 threads
3 posts
3 posts
Funding / 投融资
Public rounds & diligence fields — not investment advice
Latest: 尽调交流字段清单(公开信息) / Diligence field checklist (pub…
2026-10-23 11:30 北京时间
2026-10-23 11:30 北京时间
3 threads
3 posts
3 posts
Applications / 应用落地
Compliant application cases — not diagnosis
Latest: 免责模板:应用讨论可复制 / Disclaimer blurb for application…
2026-10-23 17:20 北京时间
2026-10-23 17:20 北京时间
3 threads
3 posts
3 posts
Services & Tools / CRO·CDMO·工具
Compare CRO/CDMO/tools from public info
Latest: 工具选型 checklist:集成、合规声明与数据驻留 / Tool selection ch…
2026-10-23 17:40 北京时间
2026-10-23 17:40 北京时间
3 threads
3 posts
3 posts
Chinese / 中文交流
Chinese-first general biotech industry talk
Latest: 中文交流区使用说明:闲聊也可以写字段 / Chinese board intro
2026-10-25 16:00 北京时间
2026-10-25 16:00 北京时间
1 threads
1 posts
1 posts
Latest activityAll threads →
0 replies
5 views
5 views
0 replies
3 views
3 views
0 replies
6 views
6 views
0 replies
5 views
5 views
0 replies
5 views
5 views
0 replies
4 views
4 views
0 replies
4 views
4 views
0 replies
6 views
6 views
0 replies
4 views
4 views
0 replies
4 views
4 views
0 replies
3 views
3 views
0 replies
4 views
4 views
0 replies
4 views
4 views
0 replies
4 views
4 views
0 replies
6 views
6 views
